First published on PoliticalCartoons.com, The Philippines, July 7, 2025 | By
Manny Francisco First published in PoliticalCartoons.com, July 8, 2025 | By Bart
van Leeuwen First published on PoliticalCartoons.com, July 8, 2025 | By Dick
Wright First published in Globe and Mail, July 7, 2025 | By Michael de Adder
Tag - VDL Pfizer texts
Ursula von der Leyen on Thursday survived a vote of confidence in her
leadership, but the event wasn’t a complete victory for the European Commission
president.
If the European Parliament motion had passed, von der Leyen and her team of
commissioners would have been forced to stand down — an unlikely scenario that
would have plunged the EU into chaos. The motion of censure instead got the
support of 175 lawmakers, well short of the two-thirds majority needed for it to
pass.
Support for von der Leyen — in the form of votes rejecting the censure motion —
came, as expected, mostly from centrist political groups, including her own
European People’s Party, the Socialists and Democrats, the liberal Renew, and
the Greens.
But on closer inspection, the support for von der Leyen was lackluster.
Just 553 of the Parliament’s 719 MEPs showed up to vote. At least part of that
absenteeism appears to have been deliberate, as 636 lawmakers cast a ballot in
the next vote on the Parliament’s schedule, which took place just minutes later.
Overall, twice as many lawmakers rejected the motion against von der Leyen as
supported it. Still, with 166 missing votes, the show of support for von der
Leyen was lukewarm.
Barely 30 percent of Italy’s MEPs voted in support of von der Leyen; half
skipped the vote. And just 32 percent of France’s EU lawmakers voted against the
motion — with one-quarter of all French MEPs not showing up to vote.
In four EU countries — Hungary, Slovakia, the Czech Republic, and also France —
the number of MEPs supporting the motion to force von der Leyen out was higher
than the number of those who voted against it.
BRUSSELS ― Ursula von der Leyen’s legacy as European Commission president will
face a huge challenge this week when the EU court rules on secret text messages
she exchanged with the boss of a drug company that agreed a multibillion-euro
vaccine deal with Brussels.
In what’s set to be a reputation-defining judgment, the Court of Justice of the
EU will decide whether by refusing to release the contents of her text
conversation with Pfizer CEO Albert Bourla the Commission breached transparency
rules.
Not only will Wednesday’s “Pfizergate” decision have sweeping implications for
how the bloc’s top officials conduct business behind closed doors, it could also
cast a shadow over von der Leyen’s second five-year term at the helm, which only
started on Dec. 1. As she battles to keep the Commission relevant amid
nationalist rhetoric growing around the bloc, she has already attracted
criticism for her tendency to centralize power and for rowing back on
green-friendly commitments.
The nub of the issue is whether text messages should be classed as documents and
therefore eligible to be published in the name of transparency. While
campaigners and many external observers say they should be treated just like any
other means of official communication when related to policymaking, the
Commission says not.
MAJOR EMBARRASSMENT
The case is legally tricky for von der Leyen because she not only personally
signed off on the bloc’s largest vaccine contract — worth billions of euros —
she also presides over the very institution tasked with enforcing EU law, which
includes principles of transparency and accountability. If the court rules
against her, it would provide political ammunition to a wide range of critics.
It would also be a major embarrassment given it’s just a few months after she
publicly pledged to defend standards of transparency, efficiency and probity in
her second term.
“This court ruling could mark a turning point for transparency in the EU,” said
Shari Hinds, EU policy officer for political integrity at the NGO Transparency
International. “When it comes to key decisions, particularly those affecting
public health, secrecy should be avoided.”
The case was instigated by The New York Times and its former Brussels bureau
chief, which brought an action against the Commission’s decision not to release
the text messages in 2022.
The existence of the messages was revealed in an April 2021 New York
Times interview, where Bourla described their exchanges as fostering “deep
trust” and facilitating the negotiation of a substantial vaccine deal. This
agreement, finalized in May 2021, involved the EU committing to purchase up to
1.8 billion doses of the Pfizer-BioNTech Covid-19 vaccine, the largest by far of
all the deals signed by Brussels.
It foresaw the up-front purchase of 900 million doses, with the option to order
900 million more, for delivery in 2022 and 2023.
WAKE-UP CALL
The European Ombudsman found in 2022 that the Commission’s failure to look for
the text messages in question amounted to maladministration. Emily O’Reilly,
ombudsman from 2013-2025 called it a “wake-up call” for the EU institutions.
She said transparency had gone backward under von der Leyen’s reign.
The agreement, finalized in May 2021, involved the EU committing to purchase up
to 1.8 billion doses of the Pfizer-BioNTech Covid-19 vaccine. | Caroline
Brehman/EPA-EFE
And she took particular aim at von der Leyen herself, accusing the Commission
president in an interview with POLITICO last year of creating a culture of
“holding things back” for political reasons.
She also criticized von der Leyen’s absence from the only court hearing held in
the case so far. “The elephant who wasn’t in the room,” she said. “The one
person who could tell us everything wasn’t there.”
In a statement to POLITICO, the Commission said that it “never denied the
exchange of text messages with the CEO of Pfizer. At that time, when the world
was going through a heavy pandemic, many leaders were in regular contact with
CEOs of pharmaceutical companies.”
Text messages being exchanged “does not mean that contracts were negotiated at
that level or even via the exchange of text messages,” it added.
The Commission said “transparency is of paramount importance for the Commission
and President von der Leyen” and that “significant progress has been made in
recent years” on “openness, accountability and clear communication.”
Judges at the lower tier of the same EU court have already ruled against the
Commission’s decision to redact large parts of the vaccine contracts before
making them available, which the executive said it had done to protect staff
privacy and companies’ commercial interests.
Tilly Metz, one of the five Green members of the European Parliament to bring
that case to the General Court, questioned who or what was behind von der
Leyen’s reluctance to share information. “She gets bad advice there,” she said.
“If you want the public to be confident and trust the politicians and what they
do — and the contacts they do with industry — you have to put the focus on
transparency.”
While she acknowledged that the Covid-19 health crisis was a “very new
situation” that led to the Commission having to collaborate with industry, she
believes that von der Leyen failed to learn the right lessons from the
pandemic.
YEARS OF AMBIGUITY
As part of the case to be decided on Wednesday, the court held a hearing in
Luxembourg in November. The court’s grand chamber signaled it was skeptical
about the Commission’s refusal to release the text messages.
After years of ambiguity even about the existence of the messages, the
Commission’s lawyers — finally — acknowledged them. That triggered laughter
among those in attendance, and also impatience among the judges.
“We don’t deny that they [the texts] exist,” said Commission lawyer Paolo
Stancanelli midway through the hearing.
The Commission’s lawyer denied their importance, saying they would have kept
them — and potentially made them available — if they were related to the
negotiations of the contract with Pfizer.
EPPO chief Laura Codruța Kövesi confirmed her office recently interviewed
Commission officials over how the vaccine negotiations were conducted. | Radek
Pietruszka/EPA
Judges showed signs of annoyance because the Commission repeatedly failed to
explain how it decided what is important or not, asking forensic questions the
Commission’s official was unable to answer: Did they ask von der Leyen directly
about the texts? Did they check her phone or invoices? Did they challenge the
head of her Cabinet?
After more than three hours of debate, judges delivered blunt criticism of the
Commission’s responses and attitude to The New York Times’ request.
One judge, José Martín y Pérez de Nanclares, said the executive had not shown
“adequate and diligent measures” to explain why they couldn’t share the texts.
Another, Paul Nihoul, slammed the “relatively confused dossier.”
Bondine Kloostra, a lawyer for The New York Times, said it was “very
disappointing how unprepared” the Commission’s representative had been in the
hearing.
“We still don’t know what happened to the phone of VDL, whether messages or
Signal messages were exchanged through a laptop or any other device; we still
don’t know where the Commission searched,” she said.
FINANCIAL CRIMES
The pressure on von der Leyen is mounting beyond this ruling. The European
Public Prosecutor’s Office, tasked with investigating serious financial crimes
against the EU’s financial interests, confirmed that it has been investigating
the Commission on its handling of the vaccine procurements.
In March, EPPO chief Laura Codruța Kövesi confirmed her office recently
interviewed Commission officials over how the vaccine negotiations were
conducted.
EPPO said it would not comment on an ongoing investigation.